Clinical trials
Phase 2 Bronchiolitis Obliterans Syndrome trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Genzyme, a Sanofi Company | 1 |
| Gilead Sciences | 1 |
| Hopital Foch | 1 |
| Sanofi | 1 |
| Syndax Pharmaceuticals | 1 |
| University Hospital, Toulouse | 1 |
| Zambon SpA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 11 |
| Leukemia | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Bone Marrow Diseases | 1 |
| Bronchial Diseases | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Diseases | 1 |
| Immune System Diseases | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Myelodysplastic Syndromes | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.